Skip to main content

XymoZyme® 120

(No reviews yet)

Acid-Resistant, Vegan-Suitable, Digestive Enzymes*

Card Subtitle:
Acid-Resistant, Vegan-Suitable, Digestive Enzymes*
Product Subtitle:
Acid-Resistant, Vegan-Suitable, Digestive Enzymes*

Product Overview


XymoZyme® is a cost-effective, non-prescription, broad-spectrum, digestive enzyme formula suitable for vegans and designed to support the digestion of fat, protein, carbohydrate, fiber, and lactose. This comprehensive formula contains lipase, proteases, alpha-galactosidase, hemicellulase, papain, lactase, and other key digestive enzymes. XymoZyme works in a wide pH range—unlike porcine pancreatin, which works in a narrow pH range.*

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Suggested Use

Take one to two capsules daily, or use as directed by your healthcare practitioner. If necessary, capsules may be opened and contents sprinkled over food.

Consult your healthcare practitioner prior to use. Individuals taking medication should discuss potential interactions with their healthcare practitioner. Do not use if tamper seal is damaged.


If you are pregnant or nursing, consult your physician before taking this product.

Supplement Facts

Serving Size: 2 Capsules
Servings Per Container: 60

  Amount Per Serving % Daily Value
Protease (pH 3.0-9.0) 120,000 HUT **
Papain (from papaya) 50,000 TU **
Bromelain (from pineapple) 120 GDU **
Amylase 4,000 SKB **
30 AG **
Cellulase 4,000 CU **
Beta-Glucanase 50 BGU **
Alpha-Galactosidase 400 GAL **
Invertase 2,000 Sumner **
Peptidase (29 DPPIV) 2,400 HUT **
Pectinase 70 Endo PG **
Lactase 700 ALU **
Phytase 20 U **
Acid Stable Protease (pH 2.0-3.5) 400 HUT **
Lipase 1,200 FIP **
Xylanase 300 XU **
Hemicellulase 200 HCU **
**Daily Value not established

Other Ingredients: HPMC (capsule), microcrystalline cellulose, stearic acid, magnesium stearate, and silica.

Made in a GMP compliant facility.



No reviews yet.